DexCom Inc (NASDAQ:DXCM)
| 405.34 BATS BZX Real-Time Price As of 11:08am ET |  +5.00 / +1.25%Today’s Change | 145.23 Today|||52-Week Range 456.23 | +85.31% Year-to-Date |
Latest DXCM News | Press Releases
Today’s Trading
| Previous close | 400.34 |
| Today’s open | 400.00 |
| Day’s range | 398.47 - 407.19 |
| Volume | 4,394 |
| Average volume (3 months) | 990,809 |
| Market cap | $38.5B |
Data as of 11:06am ET, 09/29/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +41.26% |
| Earnings growth (next 5 years) | +27.80% |
| Revenue growth (last year) | +43.08% |
| P/E ratio | 183.7 |
| Price/Sales | 13.68 |
| Price/Book | 41.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | +0.45 | +0.57% |
| ZBHZimmer Biomet Holdin... | -2.66 | -1.95% |
| BSXBoston Scientific Co... | -0.09 | -0.24% |
| WSTWest Pharmaceutical ... | +3.98 | +1.46% |
Data as of 11:11am ET, 09/29/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $101.1M |
| Net profit margin | 6.85% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
